Open-label extension trial of the safety and tolerability of OROSO methylphenidate in adults with ADHD - the long-acting methylphenidate in adult ADHD (lamda) trial

被引：0
|
作者：
Kooij, S.
Medori, R.
Buitelaar, J.
Ramos-Quiroga, J. A.
Lee, E.
Casas, M.
机构：
来源：
JOURNAL OF NEURAL TRANSMISSION | 2007年 / 114卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：XCIII / XCIII
页数：1
相关论文
共 50 条
  • [31] Safety and effectiveness of OROS*-methylphenidate in adults with attention deficit hyperactivity disorder (ADHD): Results of an open label study
    Fallu, A
    Prinzo, R
    Binder, C
    BIOLOGICAL PSYCHIATRY, 2006, 59 (08) : 114S - 114S
  • [32] Effectiveness and safety of long-acting versus short acting methylphenidate in ADHD in population between 6 and 19 years: a systematic review
    Calleja, Jose
    Uribarri, Jose
    MEDWAVE, 2012, 12 (08):
  • [33] Safety and effectiveness of OROS*Methylphenidate in adults with Attention Deficit Hyperactivity Disorder (ADHD): Results of an open label study
    Fallu, A.
    Prinzo, R.
    Binder, C.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S134 - S134
  • [34] Methylphenidate, cognition, and epilepsy: A 1-month open-label trial
    Adams, Jesse
    Alipio-Jocson, Valerie
    Inoyama, Katherine
    Bartlett, Victoria
    Sandhu, Saira
    Oso, Jemima
    Barry, John J.
    Loring, David W.
    Meador, Kimford J.
    EPILEPSIA, 2017, 58 (12) : 2124 - 2132
  • [35] Long-term safety, tolerability, and clinical efficacy of quetiapine in adolescents: An open-label extension trial
    McConville, B
    Carrero, L
    Sweitzer, D
    Potter, L
    Chaney, R
    Foster, K
    Sorter, M
    Friedman, L
    Browne, K
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2003, 13 (01) : 75 - 82
  • [36] A long-term safety study of prolonged-release methylphenidate in adults with ADHD
    Schaeuble, B.
    Singh, J.
    Adler, L. A.
    Orman, C.
    Pandina, G. J.
    Palumbo, J. M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S679 - S679
  • [37] THE EFFECTS OF LONG ACTING METHYLPHENIDATE IN ADULTS WITH ADHD: A STUDY WITH PAIRED PULSE TRANSCRANIAL MAGNETIC STIMULATION
    Schneider, M.
    Retz, W.
    Gougleris, G.
    Verhoeven, W.
    Tulen, J.
    Roesler, M.
    EUROPEAN PSYCHIATRY, 2011, 26
  • [38] 160-week interim results front an open-label extension trial of olanzapine long-acting injection
    Detke, H. C.
    McDonnell, D. P.
    Andersen, S. W.
    Watson, S. B.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 151 - 151
  • [39] Does 20 mg long-acting methylphenidate alter blood pressure and heart rate in children with ADHD?
    Wiguna, Tjhin
    Wibisono, Sasanto
    Sastroasmoro, Sudigdo
    Suyatna, Fransiscus D.
    PAEDIATRICA INDONESIANA, 2011, 51 (05) : 282 - 287
  • [40] ELAMIPRETIDE IN THE MMPOWER-2 OPEN-LABEL EXTENSION TRIAL (OLE): LONG-TERM SAFETY AND TOLERABILITY
    Karaa, Amel
    Haas, Richard
    Goldstein, Amy
    Vockley, Gerard
    Cohen, Bruce
    MUSCLE & NERVE, 2018, 58 : S34 - S34
12345